Niklas Joisten1, Felix Kummerhoff1, Christina Koliamitra1, Alexander Schenk1, David Walzik1, Luca Hardt1, Andre Knoop2, Mario Thevis2, David Kiesl3, Alan J Metcalfe1, Wilhelm Bloch1, Philipp Zimmer1,4. 1. Department for Molecular and Cellular Sports Medicine, Institute for Cardiovascular Research and Sports Medicine, German Sport University Cologne, Cologne, Germany. 2. Center for Preventive Doping Research/Institute of Biochemistry, German Sport University Cologne, Cologne, Germany. 3. University Clinic for Hematology and Internal Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria. 4. Department of "Performance and Health (Sports Medicine)", Institute of Sport and Sport Science, Technical University Dortmund, Dortmund, Germany.
Abstract
INTRODUCTION: The essential amino acid tryptophan (TRP) is primarily degraded through the kynurenine (KYN) pathway, which is dysregulated in several chronic diseases. KYN pathway metabolites have immune- and neuro-modulatory properties and are involved in th de novo synthesis of nicotinamide adenine dinucleotide (NAD+). Currently, little evidence exists demonstrating that physical exercise may influence this pathway. However, differences between acute and chronic stimuli as well as the influence of exercise modalities remain to be investigated. Here, we provide an overview of existing studies and present results of a randomized cross-over trial on acute effects of a single-bout of resistance and endurance exercise. METHODS:24 healthy male adults conducted both an acute endurance exercise (EE) and resistance exercise (RE) session. Blood samples were collected before, immediately after and one hour after cessation of each exercise session. Outcomes comprised serum levels of TRP, KYN, kynurenic acid (KA), quinolinic acid (QA) and calculated ratios. Gene expression of the enzymes indoleamine 2,3 dioxygenase (IDO) 1 and kynurenine aminotransferase (KAT) 4 was measured in peripheral blood mononuclear cells (PBMCs). Moreover, serum concentrations of the potential KYN pathway mediators interleukin (IL)-6 and cortisol were determined. Finally, we investigated baseline correlations between immune cell subsets, potential mediators and initial KYN pathway activation outcomes. RESULTS: The KYN/TRP ratio correlated positively with IL-6 and CD56bright NK-cells and negatively with CD56dim NKcells. Expression of IDO1 in PBMCs correlated positively with IL-6, regulatory T-cells and CD56bright NK-cells, whereas negative correlations to cytotoxic T-cells and CD56dim NKcells were revealed. A significant time effect on KYN/TRP ratio was detected for RE. Regarding KA and KA/KYN ratio, an increase after exercise followed by a decrease at the follow- up measurement was revealed in EE. KAT4 expression also increased after exercise in EE. Moreover, elevated QA levels were observed after the EE session. CONCLUSIONS: In contrast to chronic exercise interventions, single-bouts of endurance exercise provoke acute alterations on KYN pathway outcomes in humans. Our results indicate that EE induces stronger alterations than RE. Enhanced conversion of KYN to both, KA and QA suggest a peripheral KYN clearance, thereby preventing pathological accumulation within the CNS. Future acute and chronic exercise studies are needed to examine the role of NAD+ synthesis starting with TRP and the interplay between KYN pathway activation and mid- to long-term immunological modulations.
RCT Entities:
INTRODUCTION: The essential amino acid tryptophan (TRP) is primarily degraded through the kynurenine (KYN) pathway, which is dysregulated in several chronic diseases. KYN pathway metabolites have immune- and neuro-modulatory properties and are involved in th de novo synthesis of nicotinamide adenine dinucleotide (NAD+). Currently, little evidence exists demonstrating that physical exercise may influence this pathway. However, differences between acute and chronic stimuli as well as the influence of exercise modalities remain to be investigated. Here, we provide an overview of existing studies and present results of a randomized cross-over trial on acute effects of a single-bout of resistance and endurance exercise. METHODS: 24 healthy male adults conducted both an acute endurance exercise (EE) and resistance exercise (RE) session. Blood samples were collected before, immediately after and one hour after cessation of each exercise session. Outcomes comprised serum levels of TRP, KYN, kynurenic acid (KA), quinolinic acid (QA) and calculated ratios. Gene expression of the enzymes indoleamine 2,3 dioxygenase (IDO) 1 and kynurenine aminotransferase (KAT) 4 was measured in peripheral blood mononuclear cells (PBMCs). Moreover, serum concentrations of the potential KYN pathway mediators interleukin (IL)-6 and cortisol were determined. Finally, we investigated baseline correlations between immune cell subsets, potential mediators and initial KYN pathway activation outcomes. RESULTS: The KYN/TRP ratio correlated positively with IL-6 and CD56bright NK-cells and negatively with CD56dim NKcells. Expression of IDO1 in PBMCs correlated positively with IL-6, regulatory T-cells and CD56bright NK-cells, whereas negative correlations to cytotoxic T-cells and CD56dim NKcells were revealed. A significant time effect on KYN/TRP ratio was detected for RE. Regarding KA and KA/KYN ratio, an increase after exercise followed by a decrease at the follow- up measurement was revealed in EE. KAT4 expression also increased after exercise in EE. Moreover, elevated QA levels were observed after the EE session. CONCLUSIONS: In contrast to chronic exercise interventions, single-bouts of endurance exercise provoke acute alterations on KYN pathway outcomes in humans. Our results indicate that EE induces stronger alterations than RE. Enhanced conversion of KYN to both, KA and QA suggest a peripheral KYN clearance, thereby preventing pathological accumulation within the CNS. Future acute and chronic exercise studies are needed to examine the role of NAD+ synthesis starting with TRP and the interplay between KYN pathway activation and mid- to long-term immunological modulations.
Authors: Tim K Boßlau; Paulina Wasserfurth; Britta Krüger; Thomas Reichel; Jana Palmowski; Josefine Nebl; Christopher Weyh; Alexander Schenk; Niklas Joisten; Frank Stahl; Stefanie Thoms; Kristina Gebhardt; Andreas Hahn; Karsten Krüger Journal: Cells Date: 2021-04-23 Impact factor: 6.600
Authors: Niklas Joisten; Moritz Schumann; Alexander Schenk; David Walzik; Nils Freitag; Andre Knoop; Mario Thevis; Wilhelm Bloch; Philipp Zimmer Journal: Eur J Appl Physiol Date: 2020-04-18 Impact factor: 3.078
Authors: Ada Trepci; Sophie Imbeault; Victoria L Wyckelsma; Håkan Westerblad; Sigurd Hermansson; Daniel C Andersson; Fredrik Piehl; Tomas Venckunas; Marius Brazaitis; Sigitas Kamandulis; Lena Brundin; Sophie Erhardt; Lilly Schwieler Journal: Int J Tryptophan Res Date: 2020-12-10
Authors: Josef Isung; Mathias Granqvist; Ada Trepci; Jesse Huang; Lilly Schwieler; Marie Kierkegaard; Sophie Erhardt; Jussi Jokinen; Fredrik Piehl Journal: Sci Rep Date: 2021-01-18 Impact factor: 4.379
Authors: Alexander Schenk; Tobias Esser; André Knoop; Mario Thevis; Jan Herden; Axel Heidenreich; Wilhelm Bloch; Niklas Joisten; Philipp Zimmer Journal: Metabolites Date: 2020-12-23
Authors: Mariangela Tabone; Carlo Bressa; Jose Angel García-Merino; Diego Moreno-Pérez; Emeline Chu Van; Florence A Castelli; François Fenaille; Mar Larrosa Journal: Sci Rep Date: 2021-02-11 Impact factor: 4.379
Authors: Nadine Patt; Jan Kool; Ruth Hersche; Max Oberste; David Walzik; Niklas Joisten; Daniel Caminada; Francesca Ferrara; Roman Gonzenbach; Claudio Renato Nigg; Christian Philipp Kamm; Philipp Zimmer; Jens Bansi Journal: BMC Neurol Date: 2021-02-11 Impact factor: 2.474
Authors: Florian Javelle; Philipp Zimmer; Christopher Rumpf; Sebastian Proschinger; Alexander Schenk; Wilhelm Bloch; Amit Lampit Journal: Sports Med Date: 2021-01-04 Impact factor: 11.136
Authors: Tomasz Saran; Monika Turska; Tomasz Kocki; Magdalena Zawadka; Grzegorz Zieliński; Waldemar A Turski; Piotr Gawda Journal: Sci Rep Date: 2021-05-27 Impact factor: 4.379